<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Arch Womens Ment Health</journal-id><journal-id journal-id-type="iso-abbrev">Arch Womens Ment Health</journal-id><journal-title-group><journal-title>Archives of Women's Mental Health</journal-title></journal-title-group><issn pub-type="ppub">1434-1816</issn><issn pub-type="epub">1435-1102</issn><publisher><publisher-name>Springer Vienna</publisher-name><publisher-loc>Vienna</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39523242</article-id><article-id pub-id-type="pmc">PMC12092548</article-id>
<article-id pub-id-type="publisher-id">1531</article-id><article-id pub-id-type="doi">10.1007/s00737-024-01531-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Severe alcohol withdrawal during pregnancy or early postpartum: maternal and fetal outcomes</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Daidone</surname><given-names>Shaun</given-names></name><address><email>daidone.shaun@mayo.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Unlu</surname><given-names>Hayrunnisa</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Yehia</surname><given-names>Asmaa</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Nan</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Abulseoud</surname><given-names>Osama A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03jp40720</institution-id><institution-id institution-id-type="GRID">grid.417468.8</institution-id><institution-id institution-id-type="ISNI">0000 0000 8875 6339</institution-id><institution>Department of Psychiatry and Psychology, </institution><institution>Mayo Clinic Arizona, </institution></institution-wrap>13400 E. Shea Blvd, Scottsdale, Phoenix, AZ 85259 USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01k8vtd75</institution-id><institution-id institution-id-type="GRID">grid.10251.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 0342 6662</institution-id><institution>Department of Medical Physiology, Faculty of Medicine, </institution><institution>Mansoura University, </institution></institution-wrap>Mansoura, Egypt </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02qp3tb03</institution-id><institution-id institution-id-type="GRID">grid.66875.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0459 167X</institution-id><institution>Kern Center for the Science of Health Care Delivery, </institution><institution>Mayo Clinic, </institution></institution-wrap>Rochester, MN USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02qp3tb03</institution-id><institution-id institution-id-type="GRID">grid.66875.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0459 167X</institution-id><institution>Department of Neuroscience, Graduate School of Biomedical Sciences, </institution><institution>Mayo Clinic College of Medicine, </institution></institution-wrap>Phoenix, AZ USA </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>11</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>28</volume><issue>3</issue><fpage>623</fpage><lpage>632</lpage><history><date date-type="received"><day>2</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>30</day><month>10</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objective</title><p id="Par1">Alcohol withdrawal syndrome (AWS) during pregnancy is under-researched despite growing concerns about increased alcohol use among pregnant women. This study aims to explore the severity of AWS and its impact on maternal and fetal outcomes.</p></sec><sec><title>Methods</title><p id="Par2">This retrospective study reviewed the medical records of patients admitted to the Mayo Clinic who underwent the CIWA-Ar protocol for AWS from June 2019 through June 2022. Pregnant women identified in this cohort had their pregnancy, labor, and neonatal data analyzed for alcohol-related complications and outcomes.</p></sec><sec><title>Results</title><p id="Par3">Out of the medical records reviewed, 8 cases involved pregnant women experiencing AWS. These cases showed a high severity of withdrawal symptoms, with a median peak CIWA-Ar score of 17 (IQR&#x02009;=&#x02009;14). Maternal complications included a high rate of ICU admissions (37.5%; n&#x02009;=&#x02009;3) and significant rates of miscarriage and stillbirth (37.5%; n&#x02009;=&#x02009;3). Fetal outcomes were concerning, with 1 out of 5 (20%) neonates requiring NICU admission and experiencing conditions such as respiratory failure and neonatal abstinence syndrome. Developmental problems were noted in 2 out of 5 (40%) newborns.</p></sec><sec><title>Conclusions</title><p id="Par4">The findings highlight the severe implications of AWS during pregnancy, impacting both maternal and fetal health. The severity of AWS requires attentive clinical management and preventative interventions. Future research should focus on larger, prospective studies to better understand and address the risks associated with AWS in pregnant women and to improve health outcomes for mothers and their children.</p></sec><sec><title>Article Highlights</title><p id="Par5">&#x02022; Severe AWS during pregnancy leads to high ICU admissions and adverse neonatal outcomes.</p><p id="Par6">&#x02022; 37.5% of pregnant women with AWS experienced miscarriage or stillbirth.</p><p id="Par7">&#x02022; 20% of newborns from mothers with AWS required NICU admission for serious conditions; 40% of newborns had developmental problems.</p><p id="Par8">&#x02022; Findings underscore the need for specialized treatment protocols to improve outcomes for pregnant women and their newborns.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Alcohol withdrawal</kwd><kwd>Alcohol intoxication</kwd><kwd>Alcohol use disorder</kwd><kwd>Pregnancy</kwd><kwd>Pregnancy outcome</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag GmbH Austria, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par9">Moderate alcohol drinking to control pain&#x02014;specifically, the pain associated with &#x02018;&#x02018;female complaints,&#x02019;&#x02019; such as menstruation, pregnancy, childbirth, and menopause was recommended by 19th-century physicians (McClellan <xref ref-type="bibr" rid="CR38">2011</xref>). Two centuries later, Jones and Smith described fetal alcohol syndrome (Jones and Smith <xref ref-type="bibr" rid="CR26">1973</xref>) and raised public awareness of the deleterious long-term effects of drinking during pregnancy. Social alcohol drinking is common among women of childbearing age, leading to high rates of alcohol use during early pregnancy (Sundermann et al. <xref ref-type="bibr" rid="CR51">2021</xref>). Data from different national surveys show rates ranging between 7.6% and 17.7% (Centers for Disease, Control, and Prevention <xref ref-type="bibr" rid="CR16">2009</xref>; Agrawal et al. <xref ref-type="bibr" rid="CR4">2019</xref>; Havens et al. <xref ref-type="bibr" rid="CR24">2009</xref>; Tan et al. <xref ref-type="bibr" rid="CR52">2015</xref>; Crome and Kumar <xref ref-type="bibr" rid="CR17">2007</xref>; Centers for Disease, Control, and Prevention <xref ref-type="bibr" rid="CR16">2009</xref>) associated with 2.4% to 4.8% prevalence rates of fetal alcohol spectrum disorders (May et al. <xref ref-type="bibr" rid="CR37">2014</xref>). This bleak trajectory prompted the United States Surgeon General to issue a statement advising women who are pregnant or considering to get pregnant to abstain from using alcohol (Centers for Disease, Control, and Prevention <xref ref-type="bibr" rid="CR16">2009</xref>). Pregnant women who stop heavy drinking abruptly face the risk of alcohol withdrawal.</p><p id="Par10">Alcohol withdrawal syndrome (AWS) is a common medical condition with varying presentations from mild hangover to life-threatening seizures, and delirium tremens (Amato et al. <xref ref-type="bibr" rid="CR5">2011</xref>; Campos et al. <xref ref-type="bibr" rid="CR15">2011</xref>; Muzyk et al. <xref ref-type="bibr" rid="CR41">2013</xref>; Ntais et al. <xref ref-type="bibr" rid="CR42">2005</xref>). The recent increase in hazardous drinking among women is accompanied by corresponding increase in alcohol-related emergency room visits and instances of AWS (Dawson et al. <xref ref-type="bibr" rid="CR18">2015</xref>; Grant et al. <xref ref-type="bibr" rid="CR21">2017</xref>; Keyes et al. <xref ref-type="bibr" rid="CR28">2008</xref>; Keyes et al. <xref ref-type="bibr" rid="CR29">2019</xref>; Schimmel et al. <xref ref-type="bibr" rid="CR46">2021</xref>; Seedat et al. <xref ref-type="bibr" rid="CR47">2009</xref>; White et al. <xref ref-type="bibr" rid="CR61">2015</xref>, <xref ref-type="bibr" rid="CR62">2018</xref>; Agabio et al. <xref ref-type="bibr" rid="CR3">2017</xref>; Kang et al. <xref ref-type="bibr" rid="CR27">2020</xref>). However, there is a significant lack of information about the prevalence, clinical manifestations, treatment response, and outcomes of AWS in women, including during pregnancy (Lee et al. <xref ref-type="bibr" rid="CR32">2019</xref>; Sanvisens et al. <xref ref-type="bibr" rid="CR45">2021</xref>; Unlu et al. <xref ref-type="bibr" rid="CR58">2023</xref>, <xref ref-type="bibr" rid="CR59">2024</xref>).</p><p id="Par11">The harmful effects of alcohol consumption during pregnancy are well documented, encompassing a range of adverse maternal and fetal health outcomes. However, the impact of alcohol withdrawal during the prenatal and postpartum periods remains largely unexplored. This gap highlights the need for a better understanding of AWS's impact on maternal and fetal health (Amato et al. <xref ref-type="bibr" rid="CR5">2011</xref>; Campos et al. <xref ref-type="bibr" rid="CR15">2011</xref>; Kosten and O'Connor <xref ref-type="bibr" rid="CR31">2003</xref>; Muzyk et al. <xref ref-type="bibr" rid="CR41">2013</xref>; Ntais et al. <xref ref-type="bibr" rid="CR42">2005</xref>). Case reports on AWS during pregnancy are rare and mostly based on anecdotal evidence rather than thorough, systematic research. There is a critical need for more detailed analyses of alcohol consumption and withdrawal in pregnant women (McDonald et al. <xref ref-type="bibr" rid="CR39">2018</xref>; Bhat and Hadley <xref ref-type="bibr" rid="CR11">2015</xref>). The literature review reveals Bhat et al. and McDonald et al. to be some of the few comprehensive articles focusing on managing alcohol withdrawal in pregnant women (Bhat and Hadley <xref ref-type="bibr" rid="CR11">2015</xref>; McDonald et al. <xref ref-type="bibr" rid="CR39">2018</xref>). Bhat et al. offer preliminary recommendations and highlight the absence of defined safe alcohol levels during pregnancy, based on a case study and literature review (Bhat and Hadley <xref ref-type="bibr" rid="CR11">2015</xref>). McDonald et al. also emphasize the shortage of information on treating alcohol withdrawal in pregnancy through a clinical example and a systematic literature review (McDonald et al. <xref ref-type="bibr" rid="CR39">2018</xref>).</p><p id="Par12">This small study aims to narrow the existing knowledge gap by providing an in-depth examination of eight cases involving alcohol consumption and withdrawal during pregnancy or the postpartum period. We hypothesize that alcohol intake during pregnancy correlates with adverse health outcomes for both the mother and child. Furthermore, we propose that pregnant women experiencing alcohol withdrawal are prone to more severe AWS manifestations, consistent with patterns observed among the general female population. This is based on the recognized increased susceptibility of women to the adverse effects of alcohol, even at lower levels of consumption and after shorter durations of alcohol use, compared to men (Hernandez-Avila et al. <xref ref-type="bibr" rid="CR25">2004</xref>; Keyes et al. <xref ref-type="bibr" rid="CR30">2010</xref>; Randall et al. <xref ref-type="bibr" rid="CR44">1999</xref>).</p></sec><sec id="Sec2"><title>Methods</title><p id="Par13">The study was approved by the Institutional Review Board of Mayo Clinic (ID#22&#x02013;008591). We collected the electronic medical records of all admissions at Mayo Clinic Health System during the interval from June 2019 through June 2022 for all patients who received an order for the implementation of the Clinical Institute Withdrawal Assessment for Alcohol&#x02013;Revised (CIWA-Ar) protocol for alcohol withdrawal.</p><p id="Par14">The CIWA-Ar protocol utilizes a CIWA-Ar score based on 10 items (nausea and vomiting; tremors; sweating; anxiety; agitation; tactile disturbances; auditory disturbances; visual disturbances; headache; and disorientation or clouding of the sensorium) to quantify the severity of withdrawal manifestations on a range of 0 to 67 points (Sullivan et al. <xref ref-type="bibr" rid="CR50">1989</xref>) and administer lorazepam based on the severity score. A score 0&#x02013;9 do not receive lorazepam treatment; a score of 10&#x02013;12 receives 1&#x000a0;mg of lorazepam orally or intravenously (PO/IV); a score of 13&#x02013;14 receives 2&#x000a0;mg of lorazepam PO/IV; a score of 15&#x02013;17 receives 3&#x000a0;mg of lorazepam PO/IV; and a score of 18 or greater receives 4&#x000a0;mg of lorazepam PO/IV. AWS symptoms are reassessed 30&#x000a0;min after lorazepam administration for further dosing. This approach has been associated with lowering benzodiazepine doses, which yields less sedation, shorter hospitalizations, fewer adverse reactions, and a decreased risk of respiratory depression in comparison to fixed-dose benzodiazepine treatment (Manasco et al. <xref ref-type="bibr" rid="CR36">2012</xref>).</p><p id="Par15">All patient data were initially obtained from an electronic data extraction by senior data analysts. The active problem list at the time of admission was used to identify pregnant women during or shortly after the time of admission for alcohol withdrawal. Pregnancy, labor, and neonatal data were obtained by reviewing the medical records for each identified patient. Medical and psychiatric comorbidities and substance use profiles were all collected from the problem list and verified by reviewing the medical records. Hospital and Intensive Care Unit (ICU) length of stays (LOS) were calculated for each admission episode. The timestamps of individual CIWA-Ar assessments and benzodiazepine treatment were collected for each admission to identify the time to peak withdrawal severity and total benzodiazepine dose throughout the hospital LOS. Administered benzodiazepine doses were converted to lorazepam-equivalent doses (Brett and Murnion <xref ref-type="bibr" rid="CR13">2015</xref>). We used the revised Fenton growth chart for preterm infants to calculate the Z-Scores for head circumference and birth weight based on sex and gestational age (Fenton and Kim <xref ref-type="bibr" rid="CR19">2013</xref>).</p><p id="Par16">The normality of continuous variables was assessed using the Shapiro&#x02013;Wilk test. If normally distributed, data were presented as mean&#x02009;&#x000b1;&#x02009;standard deviation (SD) or median, inter-quartile range (IQR), and range, while categorical data were expressed as percentages.</p></sec><sec id="Sec3"><title>Results</title><sec id="Sec4"><title>Demographics</title><p id="Par17">The study included eight patients with a mean age of 28.9(&#x000b1;&#x02009;4.9) years. Six patients (75%) were single, 5 (62.5%) were unemployed, 5 (62.5%) were of non-Hispanic ethnicity and 4 (50%) were white. The patients' mean body mass index (BMI) was 29.3 (&#x000b1;&#x02009;7.1) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left" colspan="2"><italic>n</italic> (%) or mean&#x02009;&#x000b1;&#x02009;SD</th></tr></thead><tbody><tr><td align="left">Age [mean&#x02009;&#x000b1;&#x02009;SD (Min&#x02013;Max)]</td><td align="left" colspan="2">28.9&#x02009;&#x000b1;&#x02009;4.9 (20&#x02013;32)</td></tr><tr><td align="left" rowspan="3">Race</td><td align="left">White</td><td align="left">4 (50%)</td></tr><tr><td align="left">Others</td><td align="left">3 (37.5%)</td></tr><tr><td align="left">Unknown</td><td align="left">1 (12.5%)</td></tr><tr><td align="left" rowspan="3">Ethnicity</td><td align="left">Hispanic</td><td align="left">2 (25%)</td></tr><tr><td align="left">Non-hispanic</td><td align="left">5 (62.5%)</td></tr><tr><td align="left">Unknown</td><td align="left">1 (12.5%)</td></tr><tr><td align="left" rowspan="3">Marital status</td><td align="left">Single</td><td align="left">6 (75%)</td></tr><tr><td align="left">Married</td><td align="left">1 (12.5%)</td></tr><tr><td align="left">Others</td><td align="left">1 (12.5%)</td></tr><tr><td align="left" rowspan="3">Employment status</td><td align="left">Unemployed</td><td align="left">6 (75%)</td></tr><tr><td align="left">Employed</td><td align="left">0 (0.0%)</td></tr><tr><td align="left">Unknown</td><td align="left">2 (25%)</td></tr><tr><td align="left">BMI [mean&#x02009;&#x000b1;&#x02009;SD (Min&#x02013;Max)]</td><td align="left" colspan="2">29.3&#x02009;&#x000b1;&#x02009;7.1 (20.1&#x02013;37.4)</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec5"><title>Medical and psychiatric comorbidities</title><p id="Par18">Two patients (25%) had documented alcohol use disorder and 3 (37.5%) had other substance use disorder and 2 (25%) had tobacco use. Depression was reported in 6 (75%), generalized anxiety in 5 (62.5%) and history of childhood trauma or abuse in 4 (50%). Comorbid neurological conditions were reported in 4 (50%) patients and infection in 3 (37.5%) patients (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Medical and psychiatric comorbidities</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"><italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left">Alcohol use disorder</td><td align="left">2 (25%)</td></tr><tr><td align="left">Other substance dependence</td><td align="left">3 (37.5%)</td></tr><tr><td align="left">Tobacco use</td><td align="left">2 (25%)</td></tr><tr><td align="left">Depression</td><td align="left">6 (75%)</td></tr><tr><td align="left">Generalized anxiety disorder</td><td align="left">5 (62.5%)</td></tr><tr><td align="left">Childhood trauma or abuse</td><td align="left">4 (50%)</td></tr><tr><td align="left">Neurological disorders</td><td align="left">4 (50%)</td></tr><tr><td align="left">Infections</td><td align="left">3 (37.5%)</td></tr><tr><td align="left">Endocrinological disorders</td><td align="left">2 (25%)</td></tr><tr><td align="left">Respiratory disorders</td><td align="left">2 (25%)</td></tr><tr><td align="left">Anemia</td><td align="left">2 (25%)</td></tr><tr><td align="left">Gastrointestinal disorders</td><td align="left">2 (25%)</td></tr><tr><td align="left">Sleep disorders</td><td align="left">2 (25%)</td></tr><tr><td align="left">Hypothyroidism</td><td align="left">1 (12.5%)</td></tr><tr><td align="left">Nutritional disorders</td><td align="left">1 (12.5%)</td></tr><tr><td align="left">History of altered mental status</td><td align="left">1 (12.5%)</td></tr><tr><td align="left">ADHD</td><td align="left">1 (12.5%)</td></tr><tr><td align="left">PTSD</td><td align="left">1 (12.5%)</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec6"><title>Obstetrical history</title><p id="Par19">Six (75%) patients had a history of abortion. Half of the patients (n&#x02009;=&#x02009;4) had five or more pregnancies, three (37.5) had 3 full births, and two (25%) had four or more living children (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Obstetrical history</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"/><th align="left"><italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left" rowspan="3">Number of pregnancies</td><td align="left">Primigravida (1st pregnancy)</td><td align="left">1 (12.5%)</td></tr><tr><td align="left">Multigravida (2&#x02013;4 pregnancies)</td><td align="left">3 (37.5%)</td></tr><tr><td align="left">Grand multigravida (&#x02265;&#x02009;5 pregnancies)</td><td align="left">4 (50%)</td></tr><tr><td align="left" rowspan="4">Number of fullterm birth(s)</td><td align="left">0</td><td align="left">3 (37.5%)</td></tr><tr><td align="left">1</td><td align="left">1 (12.5%)</td></tr><tr><td align="left">2</td><td align="left">1 (12.5%)</td></tr><tr><td align="left">3</td><td align="left">3 (37.5%)</td></tr><tr><td align="left" rowspan="3">History of preterm labor</td><td align="left">0</td><td align="left">6 (75%)</td></tr><tr><td align="left">1</td><td align="left">2 (25%)</td></tr><tr><td align="left">2</td><td align="left">0 (0%)</td></tr><tr><td align="left" rowspan="4">Number of previous abortion(s)</td><td align="left">0</td><td align="left">2 (25%)</td></tr><tr><td align="left">1</td><td align="left">2 (25%)</td></tr><tr><td align="left">2</td><td align="left">3 (37.5%)</td></tr><tr><td align="left">3</td><td align="left">1 (12.5%)</td></tr><tr><td align="left" rowspan="5">Number of living children</td><td align="left">0</td><td align="left">3 (37.5%)</td></tr><tr><td align="left">1</td><td align="left">1 (12.5%)</td></tr><tr><td align="left">2</td><td align="left">1 (12.5%)</td></tr><tr><td align="left">3</td><td align="left">1 (12.5%)</td></tr><tr><td align="left">&#x02009;&#x02265;&#x02009;4</td><td align="left">2 (25%)</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec7"><title>Hospital course during AWS</title><p id="Par20">The median (IQR) hospital stay for patients with alcohol withdrawal syndrome (AWS) was 45 (116) hours. ICU admission was required for 37.5% of the patients (n&#x02009;=&#x02009;3), with a median ICU stay of 26 (34) hours. The median peak CIWA-Ar score was 17 (14), and the time from hospital admission to peak CIWA-Ar score was 10.5 (57) hours. Regarding medication, the median lorazepam dose equivalent administered within the first 24&#x000a0;h of hospitalization was 8 (15.8) mg, with the total dose for the hospital course being 19 (15) mg (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Hospital course during AWS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"><italic>n</italic> (%) or median (IQR)</th></tr></thead><tbody><tr><td align="left">Hospital Length of Stay [median (IQR) (hours)]</td><td align="left">45 (116)</td></tr><tr><td align="left">Required ICU admission</td><td align="left">3 (37.5%)</td></tr><tr><td align="left">ICU length of stay [median (IQR) (hours)]</td><td align="left">26 (34)</td></tr><tr><td align="left">Peak CIWA-Ar score [median (IQR)]</td><td align="left">17 (14)</td></tr><tr><td align="left">Time from hospital admission to peak CIWAAr score [median (IQR) (hours)]</td><td align="left">10.5 (57)</td></tr><tr><td align="left">Lorazepam dose equivalent within the first 24 h of hospitalization [median (IQR) (mg]</td><td align="left">8 (15.8)</td></tr><tr><td align="left">Lorazepam dose equivalent within whole course of hospitalization [median (IQR) (mg]</td><td align="left">19 (15)</td></tr><tr><td align="left">ALT (<italic>n</italic>&#x02009;=&#x02009;4) [median (IQR) (U/L)]</td><td align="left">39 (49)</td></tr><tr><td align="left">AST (<italic>n</italic>&#x02009;=&#x02009;4) [median (IQR) (U/L)]</td><td align="left">37 (19)</td></tr><tr><td align="left">Alkaline Phosphatase (n&#x02009;=&#x02009;4) [median (IQR) (U/L)]</td><td align="left">91.5 (55.5)</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec8"><title>Maternal and fetal outcomes</title><p id="Par21">During pregnancy, one patient (12.5%) experienced diabetic ketoacidosis, 2 (25%) had pre-eclampsia, and another 2 (25%) had viral infections (HSV, COVID-19). Three patients (37.5%) lost conception: one miscarriage at 13&#x000a0;weeks and two stillbirths at 29 and 34.6&#x000a0;weeks. Five patients (62.5%) gave birth to living neonates. Four (80%) had normal vaginal delivery and one (20%) had a cesarean delivery. During labor, two patients (40%) were diagnosed with genital HSV, one (20%) had an active Group &#x003b2; Streptococcal infection, and another patient (20%) had severe preeclampsia. Neonatal percentiles show low birth weights, small head circumference, and shorter lengths.</p><p id="Par22">Neonatal complications occurred in four (80%) cases. Specifically, one neonate required neonatal intensive care unit (NICU) admission, one (20%) had respiratory failure requiring intubation, another neonate had neonatal abstinence syndrome, and a fourth neonate had meconium aspiration with respiratory symptoms.</p><p id="Par23">Developmental problems were reported in 60% of the cases (n&#x02009;=&#x02009;3). Specific issues included speech delay (20%; n&#x02009;=&#x02009;1), autism (20%; n&#x02009;=&#x02009;1), feeding difficulties (20%; n&#x02009;=&#x02009;1), seizure disorder (20%; n&#x02009;=&#x02009;1), and trauma/fracture (20%; n&#x02009;=&#x02009;1). Developmental delays were noted in 40% (n&#x02009;=&#x02009;2), and laryngomalacia (20%; n&#x02009;=&#x02009;1), torticollis (20%; n&#x02009;=&#x02009;1), plagiocephaly (20%; n&#x02009;=&#x02009;1), brachycephaly (20%; n&#x02009;=&#x02009;1), hemiplegia (20%; n&#x02009;=&#x02009;1), and congenital long QT syndrome (20%; n&#x02009;=&#x02009;1) were also noted (Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>).
<table-wrap id="Tab5"><label>Table 5</label><caption><p>Maternal and fetal outcomes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2"/><th align="left" colspan="2"><italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left" rowspan="3">Maternal complications during pregnancy</td><td align="left">Diabetic keto acidosis</td><td align="left" colspan="2">1 (12.5%)</td></tr><tr><td align="left">Pre-eclampsia</td><td align="left" colspan="2">2 (25%)</td></tr><tr><td align="left">Viral Infection (HSV, COVID-19)</td><td align="left" colspan="2">2 (25%)</td></tr><tr><td align="left" rowspan="3">Maternal complications during labor</td><td align="left">Severe preeclampsia</td><td align="left" colspan="2">1 (20%)</td></tr><tr><td align="left">Group &#x003b2; Streptoccocal infection (active)</td><td align="left" colspan="2">1 (20%)</td></tr><tr><td align="left">Latent genital HSV (or history of)</td><td align="left" colspan="2">2 (40%)</td></tr><tr><td align="left" rowspan="3">Miscarriage or Stillbirth</td><td align="left">Miscarriage at 13 weeks</td><td align="left" colspan="2">1 (33.3%)</td></tr><tr><td align="left">Stillbirth at 29 weeks</td><td align="left" colspan="2">1 (33.3%)</td></tr><tr><td align="left">Stillbirth at 34.6 weeks</td><td align="left" colspan="2">1 (33.3%)</td></tr><tr><td align="left" rowspan="2">Delivery method</td><td align="left">Normal vaginal delivery</td><td align="left" colspan="2">4 (80%)</td></tr><tr><td align="left">Cesarean delivery</td><td align="left" colspan="2">1 (20%)</td></tr><tr><td align="left" rowspan="2">Gestational age at time of delivery (neonatal sex)</td><td align="left" colspan="3">Neonatal percentiles</td></tr><tr><td align="left">weight</td><td align="left">length</td><td align="left">head circumference</td></tr><tr><td align="left">36w4d (F)</td><td align="left">51</td><td align="left">41</td><td align="left">59</td></tr><tr><td align="left">39w0d (M)</td><td align="left">38</td><td align="left">54</td><td align="left">12</td></tr><tr><td align="left">39w0d (F)</td><td align="left">7</td><td align="left">0</td><td align="left">20</td></tr><tr><td align="left">35w0d (M)</td><td align="left">13</td><td align="left">11</td><td align="left">26</td></tr><tr><td align="left">37w5d (M)</td><td align="left" colspan="3">missing</td></tr><tr><td align="left" rowspan="5">Neonatal complications</td><td align="left" colspan="2">Any</td><td align="left">4 (80%)</td></tr><tr><td align="left" colspan="2">Required admission to NICU</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">Meconium Aspiration With Respiratory Symptoms</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">Respiratory Failure/Intubation</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">neonatal abstinence syndrome</td><td align="left">1 (20%)</td></tr><tr><td align="left" rowspan="13">Developmental problems</td><td align="left" colspan="2">Any</td><td align="left">3 (60%)</td></tr><tr><td align="left" colspan="2">Speech delay</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">Autism</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">Feeding difficulties</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">Seizure disorder</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">Trauma/fracture</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">Developmental delay</td><td align="left">2 (40%)</td></tr><tr><td align="left" colspan="2">Laryngomalacia</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">Torticollis</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">Plagiocephaly</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">Brachycephaly</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">Hemiplegia</td><td align="left">1 (20%)</td></tr><tr><td align="left" colspan="2">Congenital Long QT syndrome</td><td align="left">1 (20%)</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec9"><title>Substance use histories</title><p id="Par24">The ages of the patients at the time of delivery ranged from 20 to 32&#x000a0;years, with a mean age of 28.9&#x000a0;years. The interval between the alcohol withdrawal syndrome (AWS) encounter and the date of delivery varied widely, from a negative interval of -128&#x000a0;days (about 4.2&#x000a0;months after delivery) to a maximum interval of&#x02009;+&#x02009;112&#x000a0;days (about 3.7&#x000a0;months before delivery). All patients (100%) had alcohol use during pregnancy, with the duration of alcohol use prior to pregnancy ranging from 0&#x000a0;days to 20&#x000a0;years.</p><p id="Par25">Regarding other substance use during pregnancy, all 8 patients (100%) used substances in addition to alcohol. Nicotine use was the most common (75%), followed by amphetamines (50%), cannabis (25%), cocaine (25%), opioids (25%), and benzodiazepines (12.5%). Several patients also had a documented history of other substance use prior to pregnancy, with substances such as cocaine (37.5%), amphetamines (37.5%), and opioids (37.5%) reported. The number of prior hospitalizations related to substance use ranged from 0 to 5, with 5 of the patients (62.5%) having at least one hospitalization involving substance use prior to the episode of AWS (Table&#x000a0;<xref rid="Tab6" ref-type="table">6</xref>).
<table-wrap id="Tab6"><label>Table 6</label><caption><p>Substance use histories</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Patients age at date of delivery (years)</th><th align="left">Interval between alcohol withdrawal encounter date and delivery date (days)</th><th align="left">Alcohol use during pregnancy</th><th align="left">Duration of documented alcohol use disorder prior to pregnancy (years, days)</th><th align="left">Other substance use during pregnancy</th><th align="left">Other substance use prior to pregnancy</th><th align="left">Prior number of hospitalizations involving substance use</th></tr></thead><tbody><tr><td align="left">31</td><td align="left">14</td><td align="left">Yes</td><td align="left">212&#x000a0;days</td><td align="left">Nicotine</td><td align="left">Nicotine</td><td align="left">4</td></tr><tr><td align="left">23</td><td align="left">15</td><td align="left">Yes</td><td align="left">8&#x000a0;years, 178&#x000a0;days</td><td align="left">Nicotine, Cannabis, Amphetsmines, Cocaine</td><td align="left">Nicotine, Amphetsmines, Cannabis, Cocaine</td><td align="left">1</td></tr><tr><td align="left">20</td><td align="left">0</td><td align="left">Yes</td><td align="left">None documented in chart</td><td align="left">Cannabis, Cocaine</td><td align="left">None</td><td align="left">0</td></tr><tr><td align="left">32</td><td align="left">0</td><td align="left">Yes</td><td align="left">20&#x000a0;years, 237&#x000a0;days</td><td align="left">Cannabis, Amphetsmines</td><td align="left">Nicotine, Amphetsmines, Cannabis, Oploids</td><td align="left">5</td></tr><tr><td align="left">31</td><td align="left">&#x02012;36</td><td align="left">Yes</td><td align="left">1&#x000a0;year, 119&#x000a0;days</td><td align="left">Nicotine</td><td align="left">Nicotine</td><td align="left">0</td></tr><tr><td align="left">30</td><td align="left">&#x02012;128</td><td align="left">Yes</td><td align="left">9&#x000a0;years, 355&#x000a0;days</td><td align="left">Nicotine, Amphetsmines</td><td align="left">Nicotine, Amphetsmines</td><td align="left">1</td></tr><tr><td align="left">32</td><td align="left">0</td><td align="left">Yes</td><td align="left">5&#x000a0;years, 25&#x000a0;days</td><td align="left">Nicotine, Oploids</td><td align="left">Nicotine, Oploids</td><td align="left">0</td></tr><tr><td align="left">32</td><td align="left">112</td><td align="left">Yes</td><td align="left">19&#x000a0;years, 144&#x000a0;days</td><td align="left">Nicotine, Amphetsmines, Benzodiazepines, Cocaine, Oploids</td><td align="left">Nicotine, Amphetsmines, Benzodiazepines, Cocaine, Oploids</td><td align="left">4</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec10"><title>Discussion</title><p id="Par26">Our study presents one of the few detailed examinations of severe AWS during pregnancy and postpartum. Although there is limited existing data on this population, by comparing data from this research with our earlier published findings on adolescents and young adults, we can better understand AWS's impact across these demographics and during pregnancy, as both pregnant women and adolescents carry specific physiological and psychosocial challenges (Unlu et al. <xref ref-type="bibr" rid="CR59">2024</xref>). Adolescents, who are still undergoing significant development, often exhibit risk-taking behaviors and face high rates of suicidality and mental health disorders (Lees et al. <xref ref-type="bibr" rid="CR33">2020</xref>). Similarly, pregnant women undergo substantial physiological changes, such as increased alcohol clearance rate (Badger et al. <xref ref-type="bibr" rid="CR7">2005</xref>), which could theoretically intensify the impact of AWS and contribute to more severe withdrawal symptoms. The demographic differences between the adolescent cohort and the pregnant women in our study highlight the distinct nature of AWS in each group and comparing them underscores the need for tailored treatment strategies that account for their unique vulnerabilities. Additionally, the use of consistent metrics in both of our studies allows for a unique comparison of AWS severity and treatment responses across these groups.</p><p id="Par27">In pregnant women, the median peak CIWA-Ar score was 17, far exceeding the adolescent group's median of 9, indicating more severe AWS in pregnant women (Unlu et al. <xref ref-type="bibr" rid="CR59">2024</xref>). The higher ICU admission rate in this study (37.5%; n&#x02009;=&#x02009;3) compared to the adolescent group&#x02019;s admission rate (22.3%; n&#x02009;=&#x02009;33) mirrors this, and also suggests that AWS can escalate to life-threatening conditions more rapidly in pregnancy than in the general population (Bhat and Hadley <xref ref-type="bibr" rid="CR11">2015</xref>; McDonald et al. <xref ref-type="bibr" rid="CR39">2018</xref>). Additionally, pregnant women required a higher initial benzodiazepine dose (8&#x000a0;mg of lorazepam equivalent) than adolescents (2&#x000a0;mg), which also corresponded to the greater severity of their symptoms. However, they had a shorter median hospital stay (45&#x000a0;h) compared to adolescents (68.8&#x000a0;h), which was possibly due to more aggressive early treatment (Unlu et al. <xref ref-type="bibr" rid="CR59">2024</xref>).</p><p id="Par28">The severity of AWS in pregnant women may be due to physiological changes during pregnancy. Animal studies provide insights into a possible mechanism by showing that chronic alcohol exposure in pregnant rats leads to higher ethanol levels in both maternal and fetal compartments, confirming ethanol&#x02019;s ability to cross the placental barrier (Trav&#x000e9;s et al. <xref ref-type="bibr" rid="CR55">1995</xref>; Trav&#x000e9;s and L&#x000f3;pez-Tejero <xref ref-type="bibr" rid="CR56">1994</xref>; Beattie <xref ref-type="bibr" rid="CR9">1986</xref>). Additionally, these studies observed a reduction in liver alcohol dehydrogenase activity, essential for ethanol metabolism, which suggests an impaired detoxification process during pregnancy (Trav&#x000e9;s et al. <xref ref-type="bibr" rid="CR55">1995</xref>; Trav&#x000e9;s and L&#x000f3;pez-Tejero <xref ref-type="bibr" rid="CR56">1994</xref>). These findings propose a biological basis for the more severe AWS symptoms in pregnant women compared to other groups (Trav&#x000e9;s et al. <xref ref-type="bibr" rid="CR55">1995</xref>; Trav&#x000e9;s and L&#x000f3;pez-Tejero <xref ref-type="bibr" rid="CR56">1994</xref>).</p><p id="Par29">The majority of the patients had significant comorbid psychiatric conditions, with depression (75%; n&#x02009;=&#x02009;6) and generalized anxiety disorder (62.5%; n&#x02009;=&#x02009;5) being particularly prevalent. This aligns with existing literature that suggests a high co-occurrence of mood disorders and substance use disorders (Grant et al. <xref ref-type="bibr" rid="CR21">2017</xref>; Yonkers et al. <xref ref-type="bibr" rid="CR64">2017</xref>). Medical comorbidities were also commonly observed, including infectious diseases (37.5%; n&#x02009;=&#x02009;3) and neurological disorders (50%; n&#x02009;=&#x02009;4). Psychiatric comorbidities are known to play a significant role in the outcome of AWS. For example, comorbid depression is associated with increased alcohol craving severity and post-withdrawal relapse (Andersohn and Kiefer <xref ref-type="bibr" rid="CR6">2004</xref>). While there is limited data on the specific impact of psychiatric disorders on AWS during pregnancy, it is well-established that these disorders can exacerbate withdrawal symptoms, likely due to heightened physiological stress and dysregulation of the autonomic nervous system (Adinoff et al. <xref ref-type="bibr" rid="CR2">1998</xref>). Anxiety and mood disorders during pregnancy are also linked to adverse outcomes such as preterm labor, preeclampsia, and poor neonatal health, compounding the risks already associated with AWS (Abulseoud et al. <xref ref-type="bibr" rid="CR1">2023</xref>). Additionally, these psychiatric conditions often lead to increased substance use, contributing to more severe AWS and worse maternal and fetal outcomes (Caleyachetty et al. <xref ref-type="bibr" rid="CR14">2014</xref>; Volkow et al. <xref ref-type="bibr" rid="CR60">2019</xref>). The high rates of NICU admissions and developmental problems seen in our study may be influenced by this interaction between psychiatric disorders, substance use, and the demands of pregnancy.</p><p id="Par30">Substance use during pregnancy, beyond alcohol consumption, presented an additional layer of complexity. All eight patients reported using substances other than alcohol during pregnancy, with nicotine, amphetamines, and cannabis being the most prevalent. This finding aligns with existing literature, which highlights the high co-occurrence of multiple substance use in pregnant women with alcohol use disorder (Caleyachetty et al. <xref ref-type="bibr" rid="CR14">2014</xref>; Volkow et al. <xref ref-type="bibr" rid="CR60">2019</xref>). Polysubstance use during pregnancy exacerbates maternal and fetal risks, increasing the likelihood of neonatal complications such as neonatal abstinence syndrome and respiratory distress (Shankaran et al. <xref ref-type="bibr" rid="CR48">2007</xref>; Bailey and Diaz-Barbosa <xref ref-type="bibr" rid="CR8">2018</xref>). These additional substances may have contributed to the heightened severity of AWS observed in our cohort, as well as adverse maternal and neonatal outcomes.</p><p id="Par31">Alcohol withdrawal carries well-known complications due to increased CNS activity, including autonomic instability, cognitive distortions, anxiety, and seizures (Bhat and Hadley <xref ref-type="bibr" rid="CR11">2015</xref>; McDonald et al. <xref ref-type="bibr" rid="CR39">2018</xref>; Kosten and O'Connor <xref ref-type="bibr" rid="CR31">2003</xref>). These complications are thought to be caused by the abrupt cessation of GABA inhibition and a significant increase in glutamate levels (Thomas and Riley <xref ref-type="bibr" rid="CR54">1998</xref>). These biochemical changes during AWS, particularly during peak withdrawal stages, exacerbate the risk of severe complications from alcohol use alone, including congenital defects like fetal alcohol syndrome and miscarriages (Lemoine et al. <xref ref-type="bibr" rid="CR35">2003</xref>; Polygenis et al. <xref ref-type="bibr" rid="CR43">1998</xref>; Thomas and Riley <xref ref-type="bibr" rid="CR54">1998</xref>). In pregnant patients, these biological alterations can also include preterm labor, fetal distress, and placental abruption (Bhat and Hadley <xref ref-type="bibr" rid="CR11">2015</xref>; McDonald et al. <xref ref-type="bibr" rid="CR39">2018</xref>). Indeed, in our study, pregnancy complications were prevalent, including miscarriages, stillbirths, severe preeclampsia, and Group &#x003b2; streptococcal infections, which were significantly more prevalent than in the general population (Bhat and Hadley <xref ref-type="bibr" rid="CR11">2015</xref>; Bhuvaneswar et al. <xref ref-type="bibr" rid="CR12">2007</xref>; Lemoine et al. <xref ref-type="bibr" rid="CR35">2003</xref>). This highlights the high-risk nature of pregnancies complicated by AWS, and while there is extensive literature on congenital defects like fetal alcohol syndrome, limited data exists on how the severe stress of AWS may heighten these risks by further altering maternal physiology and thereby increasing the teratogenic effects on fetal development (Polygenis et al. <xref ref-type="bibr" rid="CR43">1998</xref>; Testa et al. <xref ref-type="bibr" rid="CR53">2003</xref>).</p><p id="Par32">Neonatal outcomes were also concerning, with 1 in 5 (20%) newborns requiring NICU admission and others suffering from conditions such as respiratory failure and neonatal abstinence syndrome. Developmental delays and other long-term conditions were also observed, supporting the evidence that the impacts of maternal AWS extend beyond the immediate postpartum period, potentially affecting long-term child development (Polygenis et al. <xref ref-type="bibr" rid="CR43">1998</xref>; Testa et al. <xref ref-type="bibr" rid="CR53">2003</xref>; Trofimov et al. <xref ref-type="bibr" rid="CR57">1996</xref>). One possible mechanism by which alcohol withdrawal could harm the developing fetus is related to the NMDA receptor, which binds the neurotransmitter glutamate. This receptor is vital for normal brain development (Thomas and Riley <xref ref-type="bibr" rid="CR54">1998</xref>). During withdrawal, overstimulation of the NMDA receptor may cause the death of brain cells (Thomas and Riley <xref ref-type="bibr" rid="CR54">1998</xref>) and subsequent behavioral changes related to in-utero exposure to alcohol (Thomas and Riley <xref ref-type="bibr" rid="CR54">1998</xref>). Another consideration is that while benzodiazepine use is essential for managing severe withdrawal symptoms, it also increases the risk of miscarriage, congenital malformations, and neonatal complications. Specifically, studies have shown that prenatal exposure to benzodiazepines may increase the risk of cleft palate, as well as neonatal complications like respiratory distress and neonatal benzodiazepine withdrawal after birth (Bellantuono et al. <xref ref-type="bibr" rid="CR10">2013</xref>; Freeman et al. <xref ref-type="bibr" rid="CR20">2018</xref>; Grigoriadis et al. <xref ref-type="bibr" rid="CR22">2019</xref>, <xref ref-type="bibr" rid="CR23">2020</xref>; Meng et al. <xref ref-type="bibr" rid="CR40">2024</xref>; Sheehy et al. <xref ref-type="bibr" rid="CR49">2019</xref>; Wikner et al. <xref ref-type="bibr" rid="CR63">2007</xref>; Yonkers et al. <xref ref-type="bibr" rid="CR64">2017</xref>). These withdrawal symptoms may require prolonged NICU stays and specialized care, adding to the already significant burden of managing maternal AWS during pregnancy. Additionally, prolonged use of benzodiazepines during pregnancy has been associated with later developmental delays and cognitive impairments in children (Grigoriadis et al. <xref ref-type="bibr" rid="CR23">2020</xref>). Given these risks, there is a growing need to explore alternative treatments for managing AWS during pregnancy, such as non-benzodiazepine medications like gabapentin or the use of adjunctive therapies like vitamin and supplementation to mitigate harm to the fetus (Leggio et al. <xref ref-type="bibr" rid="CR34">2008</xref>).</p><p id="Par33">The results of this study should be viewed in light of its strengths and limitations. The study provides a detailed description of the withdrawal phenotype, medical and psychiatric comorbidities, and maternal and fetal outcomes in eight patients. While this number is still very small, it is the largest sample size in the literature to our knowledge. The retrospective nature of the study limits the ability to obtain a more detailed alcohol or other substance use history. Another limitation of this study is the absence of a formal control group, such as pregnant women without AWS or non-pregnant women experiencing AWS. A comparative analysis could provide valuable insights into the differential impacts of AWS in these groups. However, due to the retrospective nature of this study and the small sample size, this was not feasible. Future research should aim to include a control group to allow for a more comprehensive understanding of how pregnancy specifically affects the severity and outcomes of AWS. In addition to the lack of a control group, several other limitations must be considered when interpreting the findings of this study. The retrospective design also introduces potential biases, such as selection bias, where only severe cases of AWS may have been captured, and information bias due to reliance on medical records, which may lack complete details. Variations in the management of AWS, including different benzodiazepine dosing and timing, could also influence the outcomes. Additionally, inconsistent follow-up durations for neonatal outcomes may have affected the detection of long-term developmental issues. Polysubstance use and psychiatric comorbidities further confound the findings, as mentioned previously, and these factors may have independently contributed to adverse maternal and fetal outcomes. Future prospective studies with standardized treatment protocols and comparison groups are needed to better understand these risks.</p><p id="Par34">Despite these limitations, our report lends more evidence to the well-known fact that AWS during pregnancy has severe implications, leading to significant maternal and neonatal complications. At-risk pregnant women require diligent monitoring, preventive strategies, and specialized care to mitigate these risks. Several key recommendations can be made to improve maternal and neonatal outcomes based on the findings of this study. First, early and routine screening for alcohol use in pregnancy is essential to identify at-risk women before the onset of severe AWS. Once identified, timely and effective treatment must be prioritized to manage AWS and mitigate associated risks. Special attention should be given to integrating addiction services into prenatal care, ensuring that pregnant women receive comprehensive, multidisciplinary support throughout their pregnancy. This should include addiction counseling, mental health services, and medical management of withdrawal symptoms. Additionally, ongoing monitoring of both maternal health and fetal development is crucial to detect complications early, allowing for interventions that can prevent more severe outcomes for both mother and child. Still, larger studies using national data are needed to identify risk factors, societal prevention measures, and pregnancy-safe pharmacological treatment options to improve mothers' and infants' outcomes.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par35">We hereby declare that none of the authors of this manuscript have any conflict of interest to disclose. All authors have no financial, personal, or other relationships with other people or organizations that could inappropriately influence, or be perceived to influence, their work.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Abulseoud</surname><given-names>OA</given-names></name><name><surname>Chan</surname><given-names>B</given-names></name><name><surname>Rivera-Chiauzzi</surname><given-names>EY</given-names></name><name><surname>Egol</surname><given-names>CJ</given-names></name><name><surname>Nettey</surname><given-names>VN</given-names></name><name><surname>Van Ligten</surname><given-names>MJ</given-names></name><name><surname>Griffin</surname><given-names>TN</given-names></name><name><surname>Aly</surname><given-names>M</given-names></name><name><surname>Sinha</surname><given-names>S</given-names></name><name><surname>Schneekloth</surname><given-names>TD</given-names></name></person-group><article-title>Psychiatric disorders during pregnancy in asymptomatic and mildly symptomatic SARS-CoV-2 positive women: Prevalence and effect on outcome</article-title><source>Psychiatry Res</source><year>2023</year><volume>326</volume><fpage>115313</fpage><pub-id pub-id-type="doi">10.1016/j.psychres.2023.115313</pub-id><pub-id pub-id-type="pmid">37336168</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Abulseoud OA, Chan B, Rivera-Chiauzzi EY, Egol CJ, Nettey VN, Van Ligten MJ, Griffin TN, Aly M, Sinha S, Schneekloth TD (2023) Psychiatric disorders during pregnancy in asymptomatic and mildly symptomatic SARS-CoV-2 positive women: Prevalence and effect on outcome. Psychiatry Res 326:115313<pub-id pub-id-type="pmid">37336168</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Adinoff</surname><given-names>B</given-names></name><name><surname>Iranmanesh</surname><given-names>A</given-names></name><name><surname>Veldhuis</surname><given-names>Jd</given-names></name><name><surname>Fisher</surname><given-names>L</given-names></name></person-group><article-title>Disturbances of the stress response: The role of the HPA axis during alcohol withdrawal and abstinence</article-title><source>Alcohol Health Res World</source><year>1998</year><volume>22</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">15706736</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Adinoff B, Iranmanesh A, Veldhuis Jd, Fisher L (1998) Disturbances of the stress response: The role of the HPA axis during alcohol withdrawal and abstinence. Alcohol Health Res World 22:67&#x02013;72<pub-id pub-id-type="pmid">15706736</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Agabio</surname><given-names>R</given-names></name><name><surname>Pisanu</surname><given-names>C</given-names></name><name><surname>Gessa</surname><given-names>GL</given-names></name><name><surname>Franconi</surname><given-names>F</given-names></name></person-group><article-title>Sex differences in alcohol use disorder</article-title><source>Curr Med Chem</source><year>2017</year><volume>24</volume><fpage>2661</fpage><lpage>2670</lpage><pub-id pub-id-type="doi">10.2174/0929867323666161202092908</pub-id><pub-id pub-id-type="pmid">27915987</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Agabio R, Pisanu C, Gessa GL, Franconi F (2017) Sex differences in alcohol use disorder. Curr Med Chem 24:2661&#x02013;2670<pub-id pub-id-type="pmid">27915987</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>A</given-names></name><name><surname>Rogers</surname><given-names>CE</given-names></name><name><surname>Lessov-Schlaggar</surname><given-names>CN</given-names></name><name><surname>Carter</surname><given-names>EB</given-names></name><name><surname>Lenze</surname><given-names>SN</given-names></name><name><surname>Grucza</surname><given-names>RA</given-names></name></person-group><article-title>Alcohol, Cigarette, and Cannabis Use Between 2002 and 2016 in Pregnant Women From a Nationally Representative Sample</article-title><source>JAMA Pediatr</source><year>2019</year><volume>173</volume><fpage>95</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1001/jamapediatrics.2018.3096</pub-id><pub-id pub-id-type="pmid">30398527</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Agrawal A, Rogers CE, Lessov-Schlaggar CN, Carter EB, Lenze SN, Grucza RA (2019) Alcohol, Cigarette, and Cannabis Use Between 2002 and 2016 in Pregnant Women From a Nationally Representative Sample. JAMA Pediatr 173:95&#x02013;96<pub-id pub-id-type="pmid">30398527</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>L</given-names></name><name><surname>Minozzi</surname><given-names>S</given-names></name><name><surname>Davoli</surname><given-names>M</given-names></name></person-group><article-title>Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome</article-title><source>Cochrane Database Syst Rev</source><year>2011</year><volume>2011</volume><fpage>Cd008537</fpage><pub-id pub-id-type="pmid">21678378</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Amato L, Minozzi S, Davoli M (2011) Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome. Cochrane Database Syst Rev 2011:Cd008537<pub-id pub-id-type="pmid">21678378</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Andersohn</surname><given-names>F</given-names></name><name><surname>Kiefer</surname><given-names>F</given-names></name></person-group><article-title>Depressive mood and craving during alcohol withdrawal: Association and interaction</article-title><source>German J Psychiatry</source><year>2004</year><volume>7</volume><fpage>6</fpage><lpage>11</lpage></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Andersohn F, Kiefer F (2004) Depressive mood and craving during alcohol withdrawal: Association and interaction. German J Psychiatry 7:6&#x02013;11</mixed-citation></citation-alternatives></ref><ref id="CR7"><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Badger</surname><given-names>TM</given-names></name><name><surname>Hidestrand</surname><given-names>M</given-names></name><name><surname>Shankar</surname><given-names>K</given-names></name><name><surname>McGuinn</surname><given-names>WD</given-names></name><name><surname>Ronis</surname><given-names>MJ</given-names></name></person-group><article-title>The effects of pregnancy on ethanol clearance</article-title><source>Life Sci</source><year>2005</year><volume>77</volume><fpage>2111</fpage><lpage>2126</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2005.02.019</pub-id><pub-id pub-id-type="pmid">15925387</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Badger TM, Hidestrand M, Shankar K, McGuinn WD, Ronis MJ (2005) The effects of pregnancy on ethanol clearance. Life Sci 77:2111&#x02013;2126<pub-id pub-id-type="pmid">15925387</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>NA</given-names></name><name><surname>Diaz-Barbosa</surname><given-names>M</given-names></name></person-group><article-title>'Effect of Maternal Substance Abuse on the Fetus</article-title><source>Neonate Child', Pediatr Rev</source><year>2018</year><volume>39</volume><fpage>550</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">30385584</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Bailey NA, Diaz-Barbosa M (2018) &#x02019;Effect of Maternal Substance Abuse on the Fetus. Neonate Child&#x02019;, Pediatr Rev 39:550&#x02013;559<pub-id pub-id-type="pmid">30385584</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Beattie</surname><given-names>JO</given-names></name></person-group><article-title>Transplacental Alcohol Intoxication</article-title><source>Alcohol Alcohol</source><year>1986</year><volume>21</volume><fpage>163</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">3741550</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Beattie JO (1986) Transplacental Alcohol Intoxication. Alcohol Alcohol 21:163&#x02013;166<pub-id pub-id-type="pmid">3741550</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Bellantuono</surname><given-names>C</given-names></name><name><surname>Tofani</surname><given-names>S</given-names></name><name><surname>Di Sciascio</surname><given-names>G</given-names></name><name><surname>Santone</surname><given-names>G</given-names></name></person-group><article-title>Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview</article-title><source>Gen Hosp Psychiatry</source><year>2013</year><volume>35</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.genhosppsych.2012.09.003</pub-id><pub-id pub-id-type="pmid">23044244</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Bellantuono C, Tofani S, Di Sciascio G, Santone G (2013) Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview. Gen Hosp Psychiatry 35:3&#x02013;8<pub-id pub-id-type="pmid">23044244</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><mixed-citation publication-type="other">Bhat A, Hadley A (2015) 'The management of alcohol withdrawal in pregnancy&#x02014;case report, literature review and preliminary recommendations', General Hospital Psychiatry, 37: 273. e1&#x02013;73. e3</mixed-citation></ref><ref id="CR12"><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Bhuvaneswar</surname><given-names>CG</given-names></name><name><surname>Chang</surname><given-names>G</given-names></name><name><surname>Epstein</surname><given-names>LA</given-names></name><name><surname>Stern</surname><given-names>TA</given-names></name></person-group><article-title>Alcohol use during pregnancy: prevalence and impact</article-title><source>Prim Care Companion J Clin Psychiatry</source><year>2007</year><volume>9</volume><fpage>455</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.4088/PCC.v09n0608</pub-id><pub-id pub-id-type="pmid">18185825</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Bhuvaneswar CG, Chang G, Epstein LA, Stern TA (2007) Alcohol use during pregnancy: prevalence and impact. Prim Care Companion J Clin Psychiatry 9:455&#x02013;460<pub-id pub-id-type="pmid">18185825</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Brett</surname><given-names>J</given-names></name><name><surname>Murnion</surname><given-names>B</given-names></name></person-group><article-title>Management of benzodiazepine misuse and dependence</article-title><source>Aust Prescr</source><year>2015</year><volume>38</volume><fpage>152</fpage><pub-id pub-id-type="doi">10.18773/austprescr.2015.055</pub-id><pub-id pub-id-type="pmid">26648651</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Brett J, Murnion B (2015) Management of benzodiazepine misuse and dependence. Aust Prescr 38:152<pub-id pub-id-type="pmid">26648651</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Caleyachetty</surname><given-names>R</given-names></name><name><surname>Tait</surname><given-names>CA</given-names></name><name><surname>Kengne</surname><given-names>AP</given-names></name><name><surname>Corvalan</surname><given-names>C</given-names></name><name><surname>Uauy</surname><given-names>R</given-names></name><name><surname>Echouffo-Tcheugui</surname><given-names>JB</given-names></name></person-group><article-title>Tobacco use in pregnant women: analysis of data from Demographic and Health Surveys from 54 low-income and middle-income countries</article-title><source>Lancet Glob Health</source><year>2014</year><volume>2</volume><fpage>e513</fpage><lpage>e520</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(14)70283-9</pub-id><pub-id pub-id-type="pmid">25304418</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Caleyachetty R, Tait CA, Kengne AP, Corvalan C, Uauy R, Echouffo-Tcheugui JB (2014) Tobacco use in pregnant women: analysis of data from Demographic and Health Surveys from 54 low-income and middle-income countries. Lancet Glob Health 2:e513&#x02013;e520<pub-id pub-id-type="pmid">25304418</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><mixed-citation publication-type="other">Campos J, Roca L, Gude F, Gonzalez&#x02010;Quintela A (2011) 'Long&#x02010;term mortality of patients admitted to the hospital with alcohol withdrawal syndrome'. Alcohol: Clin Experimental Res 35:1180&#x02013;86.</mixed-citation></ref><ref id="CR16"><mixed-citation publication-type="other">Centers for Disease, Control, and Prevention (2009) 'Alcohol use among pregnant and nonpregnant women of childbearing age - United States, 1991-2005'. MMWR Morb Mortal Wkly Rep 58:529&#x02013;532</mixed-citation></ref><ref id="CR17"><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Crome</surname><given-names>IB</given-names></name><name><surname>Kumar</surname><given-names>MT</given-names></name></person-group><article-title>Epidemiology of drug and alcohol use in young women</article-title><source>Semin Fetal Neonatal Med</source><year>2007</year><volume>12</volume><fpage>98</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.siny.2006.12.002</pub-id><pub-id pub-id-type="pmid">17292681</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Crome IB, Kumar MT (2007) Epidemiology of drug and alcohol use in young women. Semin Fetal Neonatal Med 12:98&#x02013;105<pub-id pub-id-type="pmid">17292681</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>DA</given-names></name><name><surname>Goldstein</surname><given-names>RB</given-names></name><name><surname>Saha</surname><given-names>TD</given-names></name><name><surname>Grant</surname><given-names>BF</given-names></name></person-group><article-title>Changes in alcohol consumption: United States, 2001&#x02013;2002 to 2012&#x02013;2013</article-title><source>Drug Alcohol Depend</source><year>2015</year><volume>148</volume><fpage>56</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2014.12.016</pub-id><pub-id pub-id-type="pmid">25620731</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Dawson DA, Goldstein RB, Saha TD, Grant BF (2015) Changes in alcohol consumption: United States, 2001&#x02013;2002 to 2012&#x02013;2013. Drug Alcohol Depend 148:56&#x02013;61<pub-id pub-id-type="pmid">25620731</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Fenton</surname><given-names>TR</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name></person-group><article-title>A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants</article-title><source>BMC Pediatr</source><year>2013</year><volume>13</volume><fpage>59</fpage><pub-id pub-id-type="doi">10.1186/1471-2431-13-59</pub-id><pub-id pub-id-type="pmid">23601190</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Fenton TR, Kim JH (2013) A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 13:59<pub-id pub-id-type="pmid">23601190</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>MP</given-names></name><name><surname>G&#x000f3;ez-Mogoll&#x000f3;n</surname><given-names>L</given-names></name><name><surname>McInerney</surname><given-names>KA</given-names></name><name><surname>Davies</surname><given-names>AC</given-names></name><name><surname>Church</surname><given-names>TR</given-names></name><name><surname>Sosinsky</surname><given-names>AZ</given-names></name><name><surname>Noe</surname><given-names>OB</given-names></name><name><surname>Viguera</surname><given-names>AC</given-names></name><name><surname>Cohen</surname><given-names>LS</given-names></name></person-group><article-title>Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders</article-title><source>Gen Hosp Psychiatry</source><year>2018</year><volume>53</volume><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.genhosppsych.2018.05.010</pub-id><pub-id pub-id-type="pmid">29958100</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Freeman MP, G&#x000f3;ez-Mogoll&#x000f3;n L, McInerney KA, Davies AC, Church TR, Sosinsky AZ, Noe OB, Viguera AC, Cohen LS (2018) Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders. Gen Hosp Psychiatry 53:73&#x02013;79<pub-id pub-id-type="pmid">29958100</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>BF</given-names></name><name><surname>Patricia Chou</surname><given-names>S</given-names></name><name><surname>Saha</surname><given-names>TD</given-names></name><name><surname>Pickering</surname><given-names>RP</given-names></name><name><surname>Kerridge</surname><given-names>BT</given-names></name><name><surname>June Ruan</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Jung</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>A</given-names></name></person-group><article-title>Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001&#x02013;2002 to 2012&#x02013;2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions</article-title><source>JAMA Psychiat</source><year>2017</year><volume>74</volume><fpage>911</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2017.2161</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Grant BF, Patricia Chou S, Saha TD, Pickering RP, Kerridge BT, June Ruan W, Huang B, Jung J, Zhang H, Fan A (2017) Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001&#x02013;2002 to 2012&#x02013;2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiat 74:911&#x02013;923</mixed-citation></citation-alternatives></ref><ref id="CR22"><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Grigoriadis</surname><given-names>S</given-names></name><name><surname>Graves</surname><given-names>L</given-names></name><name><surname>Peer</surname><given-names>M</given-names></name><name><surname>Mamisashvili</surname><given-names>L</given-names></name><name><surname>Dennis</surname><given-names>CL</given-names></name><name><surname>Vigod</surname><given-names>SN</given-names></name><name><surname>Steiner</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><name><surname>Cheung</surname><given-names>A</given-names></name><name><surname>Dawson</surname><given-names>H</given-names></name><name><surname>Rector</surname><given-names>N</given-names></name><name><surname>Guenette</surname><given-names>M</given-names></name><name><surname>Richter</surname><given-names>M</given-names></name></person-group><article-title>Benzodiazepine use during pregnancy alone or in combination with an antidepressant and congenital malformations: systematic review and meta-analysis</article-title><source>J Clin Psychiatry</source><year>2019</year><volume>80</volume><fpage>1845</fpage><pub-id pub-id-type="doi">10.4088/JCP.18r12412</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Grigoriadis S, Graves L, Peer M, Mamisashvili L, Dennis CL, Vigod SN, Steiner M, Brown C, Cheung A, Dawson H, Rector N, Guenette M, Richter M (2019) Benzodiazepine use during pregnancy alone or in combination with an antidepressant and congenital malformations: systematic review and meta-analysis. J Clin Psychiatry 80:1845</mixed-citation></citation-alternatives></ref><ref id="CR23"><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Grigoriadis</surname><given-names>S</given-names></name><name><surname>Graves</surname><given-names>L</given-names></name><name><surname>Peer</surname><given-names>M</given-names></name><name><surname>Mamisashvili</surname><given-names>L</given-names></name><name><surname>Ruthirakuhan</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>P</given-names></name><name><surname>Hennawy</surname><given-names>M</given-names></name><name><surname>Parikh</surname><given-names>S</given-names></name><name><surname>Vigod</surname><given-names>SN</given-names></name><name><surname>Dennis</surname><given-names>CL</given-names></name><name><surname>Steiner</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><name><surname>Cheung</surname><given-names>A</given-names></name><name><surname>Dawson</surname><given-names>H</given-names></name><name><surname>Rector</surname><given-names>N</given-names></name><name><surname>Guenette</surname><given-names>M</given-names></name><name><surname>Richter</surname><given-names>M</given-names></name></person-group><article-title>Pregnancy and Delivery Outcomes Following Benzodiazepine Exposure: A Systematic Review and Meta-analysis</article-title><source>Can J Psychiatry</source><year>2020</year><volume>65</volume><fpage>821</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1177/0706743720904860</pub-id><pub-id pub-id-type="pmid">32148076</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Grigoriadis S, Graves L, Peer M, Mamisashvili L, Ruthirakuhan M, Chan P, Hennawy M, Parikh S, Vigod SN, Dennis CL, Steiner M, Brown C, Cheung A, Dawson H, Rector N, Guenette M, Richter M (2020) Pregnancy and Delivery Outcomes Following Benzodiazepine Exposure: A Systematic Review and Meta-analysis. Can J Psychiatry 65:821&#x02013;834<pub-id pub-id-type="pmid">32148076</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Havens</surname><given-names>JR</given-names></name><name><surname>Simmons</surname><given-names>LA</given-names></name><name><surname>Shannon</surname><given-names>LM</given-names></name><name><surname>Hansen</surname><given-names>WF</given-names></name></person-group><article-title>Factors associated with substance use during pregnancy: results from a national sample</article-title><source>Drug Alcohol Depend</source><year>2009</year><volume>99</volume><fpage>89</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2008.07.010</pub-id><pub-id pub-id-type="pmid">18778900</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Havens JR, Simmons LA, Shannon LM, Hansen WF (2009) Factors associated with substance use during pregnancy: results from a national sample. Drug Alcohol Depend 99:89&#x02013;95<pub-id pub-id-type="pmid">18778900</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Avila</surname><given-names>CA</given-names></name><name><surname>Rounsaville</surname><given-names>BJ</given-names></name><name><surname>Kranzler</surname><given-names>HR</given-names></name></person-group><article-title>Opioid-, cannabis-and alcohol-dependent women show more rapid progression to substance abuse treatment</article-title><source>Drug Alcohol Depend</source><year>2004</year><volume>74</volume><fpage>265</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2004.02.001</pub-id><pub-id pub-id-type="pmid">15194204</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Hernandez-Avila CA, Rounsaville BJ, Kranzler HR (2004) Opioid-, cannabis-and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 74:265&#x02013;272<pub-id pub-id-type="pmid">15194204</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>KennethL</given-names></name><name><surname>Smith</surname><given-names>DavidW</given-names></name></person-group><article-title>Recognition of the fetal alcohol syndrome in early infancy</article-title><source>The Lancet</source><year>1973</year><volume>302</volume><fpage>999</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(73)91092-1</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Jones KennethL, Smith DavidW (1973) Recognition of the fetal alcohol syndrome in early infancy. The Lancet 302:999&#x02013;1001</mixed-citation></citation-alternatives></ref><ref id="CR27"><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>M</given-names></name><name><surname>Min</surname><given-names>A</given-names></name><name><surname>Min</surname><given-names>H</given-names></name></person-group><article-title>Gender convergence in alcohol consumption patterns: findings from the Korea National Health and Nutrition Examination Survey 2007&#x02013;2016</article-title><source>Int J Environ Res Public Health</source><year>2020</year><volume>17</volume><fpage>9317</fpage><pub-id pub-id-type="doi">10.3390/ijerph17249317</pub-id><pub-id pub-id-type="pmid">33322086</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Kang M, Min A, Min H (2020) Gender convergence in alcohol consumption patterns: findings from the Korea national health and nutrition examination survey 2007&#x02013;2016. Int J Environ Res Public Health 17:9317<pub-id pub-id-type="pmid">33322086</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Keyes</surname><given-names>KM</given-names></name><name><surname>Grant</surname><given-names>BF</given-names></name><name><surname>Hasin</surname><given-names>DS</given-names></name></person-group><article-title>Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population</article-title><source>Drug Alcohol Depend</source><year>2008</year><volume>93</volume><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2007.08.017</pub-id><pub-id pub-id-type="pmid">17980512</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Keyes KM, Grant BF, Hasin DS (2008) Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population. Drug Alcohol Depend 93:21&#x02013;29<pub-id pub-id-type="pmid">17980512</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Keyes</surname><given-names>KM</given-names></name><name><surname>Jager</surname><given-names>J</given-names></name><name><surname>Mal-Sarkar</surname><given-names>T</given-names></name><name><surname>Patrick</surname><given-names>ME</given-names></name><name><surname>Rutherford</surname><given-names>C</given-names></name><name><surname>Hasin</surname><given-names>D</given-names></name></person-group><article-title>'Is there a recent epidemic of women's drinking? A Critical Review of National Studies'</article-title><source>Alcohol: Clin Experimental Res</source><year>2019</year><volume>43</volume><fpage>1344</fpage><lpage>1359</lpage><pub-id pub-id-type="doi">10.1111/acer.14082</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Keyes KM, Jager J, Mal-Sarkar T, Patrick ME, Rutherford C, Hasin D (2019) &#x0201c;Is there a recent epidemic of women&#x02019;s drinking? A Critical Review of National Studies.&#x0201d; Alcohol: Clin Experimental Res 43:1344&#x02013;1359</mixed-citation></citation-alternatives></ref><ref id="CR30"><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Keyes</surname><given-names>KM</given-names></name><name><surname>Martins</surname><given-names>SS</given-names></name><name><surname>Blanco</surname><given-names>C</given-names></name><name><surname>Hasin</surname><given-names>DS</given-names></name></person-group><article-title>Telescoping and gender differences in alcohol dependence: new evidence from two national surveys</article-title><source>Am J Psychiatry</source><year>2010</year><volume>167</volume><fpage>969</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2009.09081161</pub-id><pub-id pub-id-type="pmid">20439391</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Keyes KM, Martins SS, Blanco C, Hasin DS (2010) Telescoping and gender differences in alcohol dependence: new evidence from two national surveys. Am J Psychiatry 167:969&#x02013;976<pub-id pub-id-type="pmid">20439391</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Kosten</surname><given-names>TR</given-names></name><name><surname>O'Connor</surname><given-names>PG</given-names></name></person-group><article-title>Management of drug and alcohol withdrawal</article-title><source>N Engl J Med</source><year>2003</year><volume>348</volume><fpage>1786</fpage><lpage>1795</lpage><pub-id pub-id-type="doi">10.1056/NEJMra020617</pub-id><pub-id pub-id-type="pmid">12724485</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Kosten TR, O&#x02019;Connor PG (2003) Management of drug and alcohol withdrawal. N Engl J Med 348:1786&#x02013;1795<pub-id pub-id-type="pmid">12724485</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JA</given-names></name><name><surname>Duby</surname><given-names>JJ</given-names></name><name><surname>Cocanour</surname><given-names>CS</given-names></name></person-group><article-title>Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome</article-title><source>Clin Toxicol</source><year>2019</year><volume>57</volume><fpage>624</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1080/15563650.2018.1542701</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Lee JA, Duby JJ, Cocanour CS (2019) Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome. Clin Toxicol 57:624&#x02013;627</mixed-citation></citation-alternatives></ref><ref id="CR33"><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Lees</surname><given-names>B</given-names></name><name><surname>Meredith</surname><given-names>LR</given-names></name><name><surname>Kirkland</surname><given-names>AE</given-names></name><name><surname>Bryant</surname><given-names>BE</given-names></name><name><surname>Squeglia</surname><given-names>LM</given-names></name></person-group><article-title>Effect of alcohol use on the adolescent brain and behavior</article-title><source>Pharmacol Biochem Behav</source><year>2020</year><volume>192</volume><fpage>172906</fpage><pub-id pub-id-type="doi">10.1016/j.pbb.2020.172906</pub-id><pub-id pub-id-type="pmid">32179028</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Lees B, Meredith LR, Kirkland AE, Bryant BE, Squeglia LM (2020) Effect of alcohol use on the adolescent brain and behavior. Pharmacol Biochem Behav 192:172906<pub-id pub-id-type="pmid">32179028</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Leggio</surname><given-names>L</given-names></name><name><surname>Kenna</surname><given-names>GA</given-names></name><name><surname>Swift</surname><given-names>RM</given-names></name></person-group><article-title>'New developments for the pharmacological treatment of alcohol withdrawal syndrome A Focus on Non-Benzodiazepine GABAergic Medications'</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><year>2008</year><volume>32</volume><fpage>1106</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.1016/j.pnpbp.2007.09.021</pub-id><pub-id pub-id-type="pmid">18029075</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Leggio L, Kenna GA, Swift RM (2008) &#x0201c;New developments for the pharmacological treatment of alcohol withdrawal syndrome A Focus on Non-Benzodiazepine GABAergic Medications.&#x0201d; Prog Neuropsychopharmacol Biol Psychiatry 32:1106&#x02013;1117<pub-id pub-id-type="pmid">18029075</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Lemoine</surname><given-names>P</given-names></name><name><surname>Harousseau</surname><given-names>H</given-names></name><name><surname>Borteyru</surname><given-names>JP</given-names></name><name><surname>Menuet</surname><given-names>JC</given-names></name></person-group><article-title>Children of Alcoholic Parents&#x02014;Observed Anomalies: Discussion of 127 Cases</article-title><source>Ther Drug Monit</source><year>2003</year><volume>25</volume><fpage>132</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1097/00007691-200304000-00002</pub-id><pub-id pub-id-type="pmid">12657907</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Lemoine P, Harousseau H, Borteyru JP, Menuet JC (2003) Children of Alcoholic Parents&#x02014;Observed Anomalies: Discussion of 127 Cases. Ther Drug Monit 25:132&#x02013;136<pub-id pub-id-type="pmid">12657907</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Manasco</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Larriviere</surname><given-names>J</given-names></name><name><surname>Hamm</surname><given-names>LL</given-names></name><name><surname>Glass</surname><given-names>M</given-names></name></person-group><article-title>Alcohol withdrawal</article-title><source>South Med J</source><year>2012</year><volume>105</volume><fpage>607</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1097/SMJ.0b013e31826efb2d</pub-id><pub-id pub-id-type="pmid">23128805</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Manasco A, Chang S, Larriviere J, Hamm LL, Glass M (2012) Alcohol withdrawal. South Med J 105:607&#x02013;612<pub-id pub-id-type="pmid">23128805</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>PA</given-names></name><name><surname>Baete</surname><given-names>A</given-names></name><name><surname>Russo</surname><given-names>J</given-names></name><name><surname>Elliott</surname><given-names>AJ</given-names></name><name><surname>Blankenship</surname><given-names>J</given-names></name><name><surname>Kalberg</surname><given-names>WO</given-names></name><name><surname>Buckley</surname><given-names>D</given-names></name><name><surname>Brooks</surname><given-names>M</given-names></name><name><surname>Hasken</surname><given-names>J</given-names></name><name><surname>Abdul-Rahman</surname><given-names>O</given-names></name><name><surname>Adam</surname><given-names>MP</given-names></name><name><surname>Robinson</surname><given-names>LK</given-names></name><name><surname>Manning</surname><given-names>M</given-names></name><name><surname>Hoyme</surname><given-names>HE</given-names></name></person-group><article-title>Prevalence and characteristics of fetal alcohol spectrum disorders</article-title><source>Pediatrics</source><year>2014</year><volume>134</volume><fpage>855</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1542/peds.2013-3319</pub-id><pub-id pub-id-type="pmid">25349310</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">May PA, Baete A, Russo J, Elliott AJ, Blankenship J, Kalberg WO, Buckley D, Brooks M, Hasken J, Abdul-Rahman O, Adam MP, Robinson LK, Manning M, Hoyme HE (2014) Prevalence and characteristics of fetal alcohol spectrum disorders. Pediatrics 134:855&#x02013;866<pub-id pub-id-type="pmid">25349310</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>McClellan</surname><given-names>ML</given-names></name></person-group><article-title>Historical perspectives on alcoholism treatment for women in the United States, 1870&#x02013;1990</article-title><source>Alcohol Treat Q</source><year>2011</year><volume>29</volume><fpage>332</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1080/07347324.2011.608597</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">McClellan ML (2011) Historical perspectives on alcoholism treatment for women in the United States, 1870&#x02013;1990. Alcohol Treat Q 29:332&#x02013;356</mixed-citation></citation-alternatives></ref><ref id="CR39"><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>PLL</given-names></name><name><surname>Jia</surname><given-names>L</given-names></name><name><surname>Vipler</surname><given-names>S</given-names></name></person-group><article-title>Alcohol withdrawal management and relapse prevention in pregnancy</article-title><source>Canadian Journal of Addiction</source><year>2018</year><volume>9</volume><fpage>32</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1097/CXA.0000000000000034</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">McDonald PLL, Jia L, Vipler S (2018) Alcohol withdrawal management and relapse prevention in pregnancy. Canadian Journal of Addiction 9:32&#x02013;41</mixed-citation></citation-alternatives></ref><ref id="CR40"><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>LC</given-names></name><name><surname>Lin</surname><given-names>CW</given-names></name><name><surname>Chuang</surname><given-names>HM</given-names></name><name><surname>Chen</surname><given-names>LK</given-names></name><name><surname>Hsiao</surname><given-names>FY</given-names></name></person-group><article-title>Benzodiazepine use during pregnancy and risk of miscarriage</article-title><source>JAMA Psychiat</source><year>2024</year><volume>81</volume><fpage>366</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2023.4912</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Meng LC, Lin CW, Chuang HM, Chen LK, Hsiao FY (2024) Benzodiazepine use during pregnancy and risk of miscarriage. JAMA Psychiat 81:366&#x02013;373</mixed-citation></citation-alternatives></ref><ref id="CR41"><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Muzyk</surname><given-names>AJ</given-names></name><name><surname>Leung</surname><given-names>JG</given-names></name><name><surname>Nelson</surname><given-names>S</given-names></name><name><surname>Embury</surname><given-names>ER</given-names></name><name><surname>Jones</surname><given-names>SR</given-names></name></person-group><article-title>The role of diazepam loading for the treatment of alcohol withdrawal syndrome in hospitalized patients</article-title><source>Am J Addict</source><year>2013</year><volume>22</volume><fpage>113</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1111/j.1521-0391.2013.00307.x</pub-id><pub-id pub-id-type="pmid">23414495</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Muzyk AJ, Leung JG, Nelson S, Embury ER, Jones SR (2013) The role of diazepam loading for the treatment of alcohol withdrawal syndrome in hospitalized patients. Am J Addict 22:113&#x02013;118<pub-id pub-id-type="pmid">23414495</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Ntais</surname><given-names>C</given-names></name><name><surname>Pakos</surname><given-names>E</given-names></name><name><surname>Kyzas</surname><given-names>P</given-names></name><name><surname>Ioannidis</surname><given-names>JPA</given-names></name></person-group><article-title>Benzodiazepines for alcohol withdrawal</article-title><source>Cochrane Database Syst Rev</source><year>2005</year><volume>9</volume><fpage>VE01</fpage></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Ntais C, Pakos E, Kyzas P, Ioannidis JPA (2005) Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 9:VE01</mixed-citation></citation-alternatives></ref><ref id="CR43"><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Polygenis</surname><given-names>D</given-names></name><name><surname>Wharton</surname><given-names>S</given-names></name><name><surname>Malmberg</surname><given-names>C</given-names></name><name><surname>Sherman</surname><given-names>N</given-names></name><name><surname>Kennedy</surname><given-names>D</given-names></name><name><surname>Koren</surname><given-names>G</given-names></name><name><surname>Einarson</surname><given-names>TR</given-names></name></person-group><article-title>Moderate alcohol consumption during pregnancy and the incidence of fetal malformations: a meta-analysis</article-title><source>Neurotoxicol Teratol</source><year>1998</year><volume>20</volume><fpage>61</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/S0892-0362(97)00073-1</pub-id><pub-id pub-id-type="pmid">9511170</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Polygenis D, Wharton S, Malmberg C, Sherman N, Kennedy D, Koren G, Einarson TR (1998) Moderate alcohol consumption during pregnancy and the incidence of fetal malformations: a meta-analysis. Neurotoxicol Teratol 20:61&#x02013;67<pub-id pub-id-type="pmid">9511170</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Randall</surname><given-names>CL</given-names></name><name><surname>Roberts</surname><given-names>JS</given-names></name><name><surname>Del Boca</surname><given-names>FK</given-names></name><name><surname>Carroll</surname><given-names>KM</given-names></name><name><surname>Connors</surname><given-names>GJ</given-names></name><name><surname>Mattson</surname><given-names>ME</given-names></name></person-group><article-title>Telescoping of landmark events associated with drinking: a gender comparison</article-title><source>J Stud Alcohol</source><year>1999</year><volume>60</volume><fpage>252</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.15288/jsa.1999.60.252</pub-id><pub-id pub-id-type="pmid">10091964</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Randall CL, Roberts JS, Del Boca FK, Carroll KM, Connors GJ, Mattson ME (1999) Telescoping of landmark events associated with drinking: a gender comparison. J Stud Alcohol 60:252&#x02013;260<pub-id pub-id-type="pmid">10091964</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Sanvisens</surname><given-names>A</given-names></name><name><surname>Zuluaga</surname><given-names>P</given-names></name><name><surname>Short</surname><given-names>A</given-names></name><name><surname>Rubio</surname><given-names>G</given-names></name><name><surname>Gual</surname><given-names>A</given-names></name><name><surname>Torrens</surname><given-names>M</given-names></name><name><surname>Fuster</surname><given-names>D</given-names></name><name><surname>Bolao</surname><given-names>F</given-names></name><name><surname>de Fonseca</surname><given-names>FR</given-names></name><name><surname>Muga</surname><given-names>R</given-names></name></person-group><article-title>Sex-specific associations of alcohol withdrawal in patients admitted for the treatment of alcohol use disorder</article-title><source>J Addiction Med</source><year>2021</year><volume>15</volume><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1097/ADM.0000000000000704</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Sanvisens A, Zuluaga P, Short A, Rubio G, Gual A, Torrens M, Fuster D, Bolao F, de Fonseca FR, Muga R (2021) Sex-specific associations of alcohol withdrawal in patients admitted for the treatment of alcohol use disorder. J Addiction Med 15:68&#x02013;73</mixed-citation></citation-alternatives></ref><ref id="CR46"><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Schimmel</surname><given-names>J</given-names></name><name><surname>Vargas-Torres</surname><given-names>C</given-names></name><name><surname>Genes</surname><given-names>N</given-names></name><name><surname>Probst</surname><given-names>MA</given-names></name><name><surname>Manini</surname><given-names>AF</given-names></name></person-group><article-title>Changes in alcohol-related hospital visits during COVID-19 in New York City</article-title><source>Addiction</source><year>2021</year><volume>116</volume><fpage>3525</fpage><lpage>3530</lpage><pub-id pub-id-type="doi">10.1111/add.15589</pub-id><pub-id pub-id-type="pmid">34060168</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Schimmel J, Vargas-Torres C, Genes N, Probst MA, Manini AF (2021) Changes in alcohol-related hospital visits during COVID-19 in New York City. Addiction 116:3525&#x02013;3530<pub-id pub-id-type="pmid">34060168</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Seedat</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>KM</given-names></name><name><surname>Angermeyer</surname><given-names>MC</given-names></name><name><surname>Berglund</surname><given-names>P</given-names></name><name><surname>Bromet</surname><given-names>EJ</given-names></name><name><surname>Brugha</surname><given-names>TS</given-names></name><name><surname>Demyttenaere</surname><given-names>K</given-names></name><name><surname>De Girolamo</surname><given-names>G</given-names></name><name><surname>Haro</surname><given-names>JM</given-names></name><name><surname>Jin</surname><given-names>R</given-names></name></person-group><article-title>Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys</article-title><source>Arch Gen Psychiatry</source><year>2009</year><volume>66</volume><fpage>785</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2009.36</pub-id><pub-id pub-id-type="pmid">19581570</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Seedat S, Scott KM, Angermeyer MC, Berglund P, Bromet EJ, Brugha TS, Demyttenaere K, De Girolamo G, Haro JM, Jin R (2009) Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry 66:785&#x02013;795<pub-id pub-id-type="pmid">19581570</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Shankaran</surname><given-names>S</given-names></name><name><surname>Lester</surname><given-names>BM</given-names></name><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Bauer</surname><given-names>CR</given-names></name><name><surname>Bada</surname><given-names>HS</given-names></name><name><surname>Lagasse</surname><given-names>L</given-names></name><name><surname>Higgins</surname><given-names>R</given-names></name></person-group><article-title>Impact of maternal substance use during pregnancy on childhood outcome</article-title><source>Semin Fetal Neonatal Med</source><year>2007</year><volume>12</volume><fpage>143</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1016/j.siny.2007.01.002</pub-id><pub-id pub-id-type="pmid">17317350</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Shankaran S, Lester BM, Das A, Bauer CR, Bada HS, Lagasse L, Higgins R (2007) Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med 12:143&#x02013;150<pub-id pub-id-type="pmid">17317350</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Sheehy</surname><given-names>O</given-names></name><name><surname>Zhao</surname><given-names>JP</given-names></name><name><surname>B&#x000e9;rard</surname><given-names>A</given-names></name></person-group><article-title>Association Between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion</article-title><source>JAMA Psychiat</source><year>2019</year><volume>76</volume><fpage>948</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2019.0963</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Sheehy O, Zhao JP, B&#x000e9;rard A (2019) Association Between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion. JAMA Psychiat 76:948&#x02013;957</mixed-citation></citation-alternatives></ref><ref id="CR50"><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>JT</given-names></name><name><surname>Sykora</surname><given-names>K</given-names></name><name><surname>Schneiderman</surname><given-names>J</given-names></name><name><surname>Naranjo</surname><given-names>CA</given-names></name><name><surname>Sellers</surname><given-names>EM</given-names></name></person-group><article-title>Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)</article-title><source>Br J Addict</source><year>1989</year><volume>84</volume><fpage>1353</fpage><lpage>1357</lpage><pub-id pub-id-type="doi">10.1111/j.1360-0443.1989.tb00737.x</pub-id><pub-id pub-id-type="pmid">2597811</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84:1353&#x02013;1357<pub-id pub-id-type="pmid">2597811</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><mixed-citation publication-type="other">Sundermann AC, Velez Edwards DR, Slaughter JC, Wu P, Jones SH, Torstenson ES, Hartmann KE (2021) 'Week-by-week alcohol consumption in early pregnancy and spontaneous abortion risk: a prospective cohort study', Am J Obstet Gynecol, 224: 97 e1&#x02013;97 e16.</mixed-citation></ref><ref id="CR52"><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>CH</given-names></name><name><surname>Denny</surname><given-names>CH</given-names></name><name><surname>Cheal</surname><given-names>NE</given-names></name><name><surname>Sniezek</surname><given-names>JE</given-names></name><name><surname>Kanny</surname><given-names>D</given-names></name></person-group><article-title>Alcohol use and binge drinking among women of childbearing age - United States, 2011&#x02013;2013</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2015</year><volume>64</volume><fpage>1042</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6437a3</pub-id><pub-id pub-id-type="pmid">26401713</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Tan CH, Denny CH, Cheal NE, Sniezek JE, Kanny D (2015) Alcohol use and binge drinking among women of childbearing age - United States, 2011&#x02013;2013. MMWR Morb Mortal Wkly Rep 64:1042&#x02013;1046<pub-id pub-id-type="pmid">26401713</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Testa</surname><given-names>M</given-names></name><name><surname>Quigley</surname><given-names>BM</given-names></name><name><surname>Eiden</surname><given-names>RD</given-names></name></person-group><article-title>The effects of prenatal alcohol exposure on infant mental development: a meta-analytical review</article-title><source>Alcohol Alcohol</source><year>2003</year><volume>38</volume><fpage>295</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1093/alcalc/agg087</pub-id><pub-id pub-id-type="pmid">12814894</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Testa M, Quigley BM, Eiden RD (2003) The effects of prenatal alcohol exposure on infant mental development: a meta-analytical review. Alcohol Alcohol 38:295&#x02013;304<pub-id pub-id-type="pmid">12814894</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>JD</given-names></name><name><surname>Riley</surname><given-names>EP</given-names></name></person-group><article-title>Fetal alcohol syndrome: does alcohol withdrawal play a role?</article-title><source>Alcohol Health Res World</source><year>1998</year><volume>22</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">15706733</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Thomas JD, Riley EP (1998) Fetal alcohol syndrome: does alcohol withdrawal play a role? Alcohol Health Res World 22:47&#x02013;53<pub-id pub-id-type="pmid">15706733</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Trav&#x000e9;s</surname><given-names>C</given-names></name><name><surname>Camps</surname><given-names>L</given-names></name><name><surname>L&#x000f3;pez-Tejero</surname><given-names>D</given-names></name></person-group><article-title>Liver alcohol dehydrogenase activity and ethanol levels during chronic ethanol intake in pregnant rats and their offspring</article-title><source>Pharmacol Biochem Behav</source><year>1995</year><volume>52</volume><fpage>93</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/0091-3057(95)00019-S</pub-id><pub-id pub-id-type="pmid">7501685</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Trav&#x000e9;s C, Camps L, L&#x000f3;pez-Tejero D (1995) Liver alcohol dehydrogenase activity and ethanol levels during chronic ethanol intake in pregnant rats and their offspring. Pharmacol Biochem Behav 52:93&#x02013;99<pub-id pub-id-type="pmid">7501685</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Trav&#x000e9;s</surname><given-names>C</given-names></name><name><surname>L&#x000f3;pez-Tejero</surname><given-names>D</given-names></name></person-group><article-title>Ethanol elimination in alcohol-treated pregnant rats</article-title><source>Alcohol Alcohol</source><year>1994</year><volume>29</volume><fpage>385</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">7986275</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Trav&#x000e9;s C, L&#x000f3;pez-Tejero D (1994) Ethanol elimination in alcohol-treated pregnant rats. Alcohol Alcohol 29:385&#x02013;395<pub-id pub-id-type="pmid">7986275</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Trofimov</surname><given-names>SS</given-names></name><name><surname>Ostrovskaia</surname><given-names>RU</given-names></name><name><surname>Smol'nikova</surname><given-names>NM</given-names></name><name><surname>Nemova</surname><given-names>EP</given-names></name><name><surname>Voronina</surname><given-names>TA</given-names></name></person-group><article-title>The significance of perinatal alcoholization and its withdrawal in the development of late cognitive disorders in rats</article-title><source>Eksp Klin Farmakol</source><year>1996</year><volume>59</volume><fpage>44</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">8974565</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Trofimov SS, Ostrovskaia RU, Smol&#x02019;nikova NM, Nemova EP, Voronina TA (1996) The significance of perinatal alcoholization and its withdrawal in the development of late cognitive disorders in rats. Eksp Klin Farmakol 59:44&#x02013;46<pub-id pub-id-type="pmid">8974565</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Unlu</surname><given-names>H</given-names></name><name><surname>Macaron</surname><given-names>MM</given-names></name><name><surname>Ayraler Taner</surname><given-names>H</given-names></name><name><surname>Kaba</surname><given-names>D</given-names></name><name><surname>Akin Sari</surname><given-names>B</given-names></name><name><surname>Schneekloth</surname><given-names>TD</given-names></name><name><surname>Leggio</surname><given-names>L</given-names></name><name><surname>Abulseoud</surname><given-names>OA</given-names></name></person-group><article-title>Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies</article-title><source>Front Psychiatry</source><year>2023</year><volume>14</volume><fpage>1266424</fpage><pub-id pub-id-type="doi">10.3389/fpsyt.2023.1266424</pub-id><pub-id pub-id-type="pmid">37810604</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Unlu H, Macaron MM, Ayraler Taner H, Kaba D, Akin Sari B, Schneekloth TD, Leggio L, Abulseoud OA (2023) Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies. Front Psychiatry 14:1266424<pub-id pub-id-type="pmid">37810604</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><mixed-citation publication-type="other">Unlu H, Yehia A, El-Gayar S, Havanur A, Deceus F, Brown SJ, Umar SB, Croarkin PE, Schneekloth TD, Abulseoud OA (2024) 'Clinical Characteristics and Treatment Outcomes of Alcohol Withdrawal Syndrome in Adolescents and Young Adults', JAACAP Open. 10.1016/j.jaacop.2024.01.012</mixed-citation></ref><ref id="CR60"><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Volkow</surname><given-names>ND</given-names></name><name><surname>Han</surname><given-names>B</given-names></name><name><surname>Compton</surname><given-names>WM</given-names></name><name><surname>McCance-Katz</surname><given-names>EF</given-names></name></person-group><article-title>Self-reported medical and nonmedical cannabis use among pregnant women in the United States</article-title><source>JAMA</source><year>2019</year><volume>322</volume><fpage>167</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1001/jama.2019.7982</pub-id><pub-id pub-id-type="pmid">31211824</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Volkow ND, Han B, Compton WM, McCance-Katz EF (2019) Self-reported medical and nonmedical cannabis use among pregnant women in the United States. JAMA 322:167&#x02013;169<pub-id pub-id-type="pmid">31211824</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><mixed-citation publication-type="other">White A, Castle I&#x02010;JP, Chen CM, Shirley M, Roach D, Hingson R (2015) 'Converging patterns of alcohol use and related outcomes among females and males in the United States, 2002 to 2012'. Alcohol: Clin Experimental Res 39:1712&#x02013;26.</mixed-citation></ref><ref id="CR62"><mixed-citation publication-type="other">White AM, Slater ME, Ng G, Hingson R, Breslow R (2018) 'Trends in alcohol&#x02010;related emergency department visits in the United States: results from the Nationwide Emergency Department Sample, 2006 to 2014', Alcohol: Clin Experimental Res, 42: 352&#x02013;59.</mixed-citation></ref><ref id="CR63"><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Wikner</surname><given-names>BN</given-names></name><name><surname>Stiller</surname><given-names>CO</given-names></name><name><surname>Bergman</surname><given-names>U</given-names></name><name><surname>Asker</surname><given-names>C</given-names></name><name><surname>K&#x000e4;ll&#x000e9;n</surname><given-names>B</given-names></name></person-group><article-title>Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations</article-title><source>Pharmacoepidemiol Drug Saf</source><year>2007</year><volume>16</volume><fpage>1203</fpage><lpage>1210</lpage><pub-id pub-id-type="doi">10.1002/pds.1457</pub-id><pub-id pub-id-type="pmid">17894421</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Wikner BN, Stiller CO, Bergman U, Asker C, K&#x000e4;ll&#x000e9;n B (2007) Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf 16:1203&#x02013;1210<pub-id pub-id-type="pmid">17894421</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Yonkers</surname><given-names>KA</given-names></name><name><surname>Gilstad-Hayden</surname><given-names>K</given-names></name><name><surname>Forray</surname><given-names>A</given-names></name><name><surname>Lipkind</surname><given-names>HS</given-names></name></person-group><article-title>'Association of Panic Disorder Generalized Anxiety Disorder, and Benzodiazepine Treatment during Pregnancy with Risk of Adverse Birth Outcomes'</article-title><source>JAMA Psychiatry</source><year>2017</year><volume>74</volume><fpage>1145</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2017.2733</pub-id><pub-id pub-id-type="pmid">28903165</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Yonkers KA, Gilstad-Hayden K, Forray A, Lipkind HS (2017) &#x0201c;Association of Panic Disorder Generalized Anxiety Disorder, and Benzodiazepine Treatment during Pregnancy with Risk of Adverse Birth Outcomes.&#x0201d; JAMA Psychiatry 74:1145&#x02013;1152<pub-id pub-id-type="pmid">28903165</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><mixed-citation publication-type="other">(2012) 'Alcohol use and binge drinking among women of childbearing age--United States, 2006&#x02013;2010', MMWR Morb Mortal Wkly Rep 61:534&#x02013;8</mixed-citation></ref></ref-list></back></article>